Source: International Congress 2016 – ILD: from the bench to the bedside
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael Kreuter (Heidelberg, Germany), Michael Kreuter, Felix J.F. Herth, Margarethe Wacker, Peter Hammerl, Conrad Wiederhold, Reiner Leidl, Andreas Hellmann, Michael Pfeifer, Jürgen Behr, Sabine Witt, Dagmar Kauschka, Marcus Mall, Andreas Günther, Philip Markart. Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases). Eur Respir J 2016; 48: Suppl. 60, 3905

Member's Comments

No comment yet.

Related content which might interest you: Interim analysis of the EXCITING-ILD registry Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Predicting mortality in idiopathic pulmonary fibrosis. Which parameters should be used to determine eligibility for treatment? Analysis of a UK prospective cohort Source: International Congress 2016 – The best is yet to come in terms of lung function Year: 2016 Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs) Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 An international survey on genetics in clinical practice for interstitial lung disease. Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Clinical study of pediatric interstitial lung diseases in China Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Healthcare utilisation in childhood interstitial lung diseases: Analysis of chILD-EU registry data Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting Source: International Congress 2014 – ILDs 6 Year: 2014 Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry Source: International Congress 2016 – IPF clinical Year: 2016 Interstitial lung diseases in children: The French national cohort study Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011 Epidemiology of interstitial lung diseases. The RENIA study Source: Eur Respir J 2001; 18: Suppl. 33, 440s Year: 2001 Assessment of fibrosis in lung biopsies from the European childhood interstitial lung disease (chILD) registry Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations Source: ERS webinar 2020: COVID-19 and the management of Interstitial Lung Diseases patients: challenges and recommendations Year: 2020 Clinical use of interstitial lung disease guidelines Source: Eur Respir Mon; 2009: 46: 386–395 Year: 2009 Validation of the COPD lung cancer screening score in a community based cohort of COPD patients Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Clinical highlights from the 2011 ERS Congress in Amsterdam Source: Eur Respir J 2012; 39: 1501-1510 Year: 2012 Nationwide survey of physicians' attitude and approach to the clinical evaluation of interstitial lung disease in Singapore Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011